SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-18-001016
Filing Date
2018-02-23
Accepted
2018-02-23 16:21:59
Documents
82
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2234562z10-k.htm 10-K 1542867
2 EX-10.76 a2234562zex-10_76.htm EX-10.76 47283
3 EX-21.1 a2234562zex-21_1.htm EX-21.1 4399
4 EX-23.1 a2234562zex-23_1.htm EX-23.1 6610
5 EX-31 a2234562zex-31.htm EX-31 8231
6 EX-32 a2234562zex-32.htm EX-32 4928
13 G516278.JPG g516278.jpg GRAPHIC 82557
  Complete submission text file 0001047469-18-001016.txt   9786113

Data Files

Seq Description Document Type Size
7 EX-101.INS inva-20171231.xml EX-101.INS 2582292
8 EX-101.SCH inva-20171231.xsd EX-101.SCH 73970
9 EX-101.CAL inva-20171231_cal.xml EX-101.CAL 81844
10 EX-101.DEF inva-20171231_def.xml EX-101.DEF 314370
11 EX-101.LAB inva-20171231_lab.xml EX-101.LAB 686895
12 EX-101.PRE inva-20171231_pre.xml EX-101.PRE 524144
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 18636817
SIC: 2834 Pharmaceutical Preparations